D-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain

Neurobiology of Aging

Volumn 36, Issue 5, 2015, Pages 1890-1902

  Cristino, Luigia ^a   Luongo, Livio ^b   Squillace, Marta ^c   Paolone, Giovanna ^d   Mango, Dalila ^e   Piccinin, Sonia ^e   Zianni, Elisa ^f   Imperatore, Roberta ^a   Iannotta, Monica ^b   Longo, Francesco ^d   Errico, Francesco ^c,g   Vescovi, Angelo Luigi ^h   Morari, Michele ^d   Maione, Sabatino ^b   Gardoni, Fabrizio ^f   Nisticò, Robert ^e,i   Usiello, Alessandro ^b,c  

^a CNR   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e European Center for Brain Research   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

D aspartate; D aspartate oxidase; Glutamate; Hippocampus; Microglia; Prefrontal cortex

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ASPARTATE OXIDASE; CASPASE 3; CASPASE 7; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; DDO PROTEIN, HUMAN; DEXTRO ASPARTIC ACID; GLUTAMIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL FRACTIONATION; CONTROLLED STUDY; GLUTAMATERGIC SYNAPSE; MICROGLIA; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTOSOME; ANIMAL; GENETICS; HOMEOSTASIS; KNOCKOUT MOUSE; METABOLISM; MUTATION; NEURODEGENERATIVE DISEASES; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ASTROCYTES; CASPASE 3; CASPASE 7; D-ASPARTATE OXIDASE; D-ASPARTIC ACID; GLUTAMATES; HOMEOSTASIS; MICE, KNOCKOUT; MICROGLIA; MUTATION; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84929416519     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.02.003     Document Type: Article

References (53)

1. Billard J.M. D-amino acids in brain neurotransmission and synaptic plasticity. Amino Acids 2012, 43:1851-1860.
2. Coyle J.T., Tsai G., Goff D.C. Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr. Drug Targets CNS Neurol. Disord. 2002, 1:183-189.
3. Cristino L., Busetto G., Imperatore R., Ferrandino I., Palomba L., Silvestri C., Petrosino S., Orlando P., Bentivoglio M., Mackie K., Di Marzo V. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E2229-E2238.
4. D'Aniello A., Vetere A., Petrucelli L. Further study on the specificity of D-amino acid oxidase and D-aspartate oxidase and time course for complete oxidation of D-amino acids. Comp. Biochem. Physiol. 1993, 105:731-734.
5. Dantzer R., Walker A.K. Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?. J.Neural Transm. 2014, 121:925-932.
6. Duncan G.E., Moy S.S., Perez A., Eddy D.M., Zinzow W.M., Lieberman J.A., Snouwaert J.N., Koller B.H. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav. Brain Res. 2004, 153:507-519.
7. Dunlop D.S., Neidle A., McHale D., Dunlop D.M., Lajtha A. The presence of free D-aspartic acid in rodents and man. Biochem. Biophys. Res. Commun. 1986, 141:27-32.
8. Errico F., Bonito-Oliva A., Bagetta V., Vitucci D., Romano R., Zianni E., Napolitano F., Marinucci S., Di Luca M., Calabresi P., Fisone G., Carta M., Picconi B., Gardoni F., Usiello A. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia. Exp. Neurol. 2011, 232:240-250.
9. Errico F., D'Argenio V., Sforazzini F., Iasevoli F., Squillace M., Guerri G., Napolitano F., Angrisano T., Di Maio A., Keller S., Vitucci D., Galbusera A., Chiariotti L., Bertolino A., de Bartolomeis A., Salvatore F., Gozzi A., Usiello A. Arole for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice. Transl. Psychiatry 2015, 5:e512.
10. Errico F., Napolitano F., Nistico R., Usiello A. New insights on the role of free D-aspartate in the mammalian brain. Amino Acids 2012, 43:1861-1871.
11. Errico F., Napolitano F., Squillace M., Vitucci D., Blasi G., de Bartolomeis A., Bertolino A., D'Aniello A., Usiello A. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia. J.Psychiatr. Res. 2013, 47:1432-1437.
12. Errico F., Nistico R., Di Giorgio A., Squillace M., Vitucci D., Galbusera A., Piccinin S., Mango D., Fazio L., Middei S., Trizio S., Mercuri N.B., Teule M.A., Centonze D., Gozzi A., Blasi G., Bertolino A., Usiello A. Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals. Transl. Psychiatry 2014, 4:e417.
13. Errico F., Nistico R., Napolitano F., Mazzola C., Astone D., Pisapia T., Giustizieri M., D'Aniello A., Mercuri N.B., Usiello A. Increased D-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice. Neurobiol. Aging 2011, 32:2229-2243.
14. Errico F., Nistico R., Napolitano F., Oliva A.B., Romano R., Barbieri F., Florio T., Russo C., Mercuri N.B., Usiello A. Persistent increase of D-aspartate in D-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay. Neurobiol. Aging 2011, 32:2061-2074.
15. Errico F., Nistico R., Palma G., Federici M., Affuso A., Brilli E., Topo E., Centonze D., Bernardi G., Bozzi Y., D'Aniello A., Di Lauro R., Mercuri N.B., Usiello A. Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility. Mol. Cell Neurosci. 2008, 37:236-246.
16. Errico F., Pirro M.T., Affuso A., Spinelli P., De Felice M., D'Aniello A., Di Lauro R. Aphysiological mechanism to regulate D-aspartic acid and NMDA levels in mammals revealed by D-aspartate oxidase deficient mice. Gene 2006, 374:50-57.
17. Errico F., Rossi S., Napolitano F., Catuogno V., Topo E., Fisone G., D'Aniello A., Centonze D., Usiello A. D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. J.Neurosci. 2008, 28:10404-10414.
18. Gardoni F., Picconi B., Ghiglieri V., Polli F., Bagetta V., Bernardi G., Cattabeni F., Di Luca M., Calabresi P. Acritical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J.Neurosci. 2006, 26:2914-2922.
19. Hashimoto A., Kumashiro S., Nishikawa T., Oka T., Takahashi K., Mito T., Takashima S., Doi N., Mizutani Y., Yamazaki T., Kaneko T., Ootomo E. Embryonic development and postnatal changes in free D-aspartate and D-serine in the human prefrontal cortex. J.Neurochem. 1993, 61:348-351.
20. Hashimoto A., Oka T., Nishikawa T. Anatomical distribution and postnatal changes in endogenous free D-aspartate and D-serine in rat brain and periphery. Eur. J. Neurosci. 1995, 7:1657-1663.
21. Hutson P.H., Sarna G.S., Kantamaneni B.D., Curzon G. Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis. J.Neurochem. 1985, 44:1266-1273.
22. Jo J., Whitcomb D.J., Olsen K.M., Kerrigan T.L., Lo S.C., Bru-Mercier G., Dickinson B., Scullion S., Sheng M., Collingridge G., Cho K. Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1, and GSK-3beta. Nat. Neurosci. 2011, 14:545-547.
23. Kleim J.A., Lussnig E., Schwarz E.R., Comery T.A., Greenough W.T. Synaptogenesis and Fos expression in the motor cortex of the adult rat after motor skill learning. J.Neurosci. 1996, 16:4529-4535.
24. Kreisel T., Frank M.G., Licht T., Reshef R., Ben-Menachem-Zidon O., Baratta M.V., Maier S.F., Yirmiya R. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol. Psychiatry 2014, 19:699-709.
25. Lakhani S.A., Masud A., Kuida K., Porter G.A., Booth C.J., Mehal W.Z., Inayat I., Flavell R.A. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 2006, 311:847-851.
26. Lee J.A., Homma H., Tashiro K., Iwatsubo T., Imai K. D-aspartate localization in the rat pituitary gland and retina. Brain Res. 1999, 838:193-199.
27. Mabrouk O.S., Marti M., Morari M. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naive and nociceptin/orphanin FQ receptor knockout mice. Neuroscience 2010, 166:40-48.
28. Malinow R., Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 2002, 25:103-126.
29. Marti M., Mela F., Bianchi C., Beani L., Morari M. Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata invivo: opposite role for D1 and D2 receptors. J.Neurochem. 2002, 83:635-644.
30. Marti M., Mela F., Ulazzi L., Hanau S., Stocchi S., Paganini F., Beani L., Bianchi C., Morari M. Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington's disease. Eur. J. Neurosci. 2003, 18:759-767.
31. Marti M., Trapella C., Viaro R., Morari M. The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway. J.Neurosci. 2007, 27:1297-1307.
32. Martineau M., Baux G., Mothet J.P. D-serine signalling in the brain: friend and foe. Trends Neurosci. 2006, 29:481-491.
33. Mela F., Marti M., Ulazzi L., Vaccari E., Zucchini S., Trapella C., Salvadori S., Beani L., Bianchi C., Morari M. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex. Eur. J. Neurosci. 2004, 19:1317-1324.
34. Mellone M., Gardoni F. Modulation of NMDA receptor at the synapse: promising therapeutic interventions in disorders of the nervous system. Eur. J. Pharmacol. 2013, 719:75-83.
35. Mothet J.P., Snyder S.H. Brain D-amino acids: a novel class of neuromodulators. Amino Acids 2012, 43:1809-1810.
36. Muller N. Inflammation and the glutamate system in schizophrenia: implications for therapeutic targets and drug development. Expert Opin. Ther. Targets 2008, 12:1497-1507.
37. Neidle A., Dunlop D.S. Developmental changes in free D-aspartic acid in the chicken embryo and in the neonatal rat. Life Sci. 1990, 46:1517-1522.
38. Nistico R., Mango D., Mandolesi G., Piccinin S., Berretta N., Pignatelli M., Feligioni M., Musella A., Gentile A., Mori F., Bernardi G., Nicoletti F., Mercuri N.B., Centonze D. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. PLoS One 2013, 8:e54666.
39. Ota N., Shi T., Sweedler J.V. D-Aspartate acts as a signaling molecule in nervous and neuroendocrine systems. Amino Acids 2012, 43:1873-1886.
40. Paoletti P., Bellone C., Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat. Rev. Neurosci. 2013, 14:383-400.
41. Ringheim G.E., Szczepanik A.M. Brain inflammation, cholesterol, and glutamate as interconnected participants in the pathology of Alzheimer's disease. Curr. Pharm. Des. 2006, 12:719-738.
42. Rosenzweig E.S., Barnes C.A. Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog. Neurobiol. 2003, 69:143-179.
43. Sakai K., Homma H., Lee J.A., Fukushima T., Santa T., Tashiro K., Iwatsubo T., Imai K. Localization of D-aspartic acid in elongate spermatids in rat testis. Arch. Biochem. Biophys. 1998, 351:96-105.
44. Sanz-Clemente A., Gray J.A., Ogilvie K.A., Nicoll R.A., Roche K.W. Activated CaMKII couples GluN2B and casein kinase 2 to control synaptic NMDA receptors. Cell Rep. 2013, 3:607-614.
45. Shalini S., Dorstyn L., Dawar S., Kumar S. Old, new and emerging functions of caspases. Cell Death Differ. 2014, http://dx.doi.org/10.1038/cdd.2014.216. [Epub ahead of print].
46. Snyder S.H., Kim P.M. D-amino acids as putative neurotransmitters: focus on D-serine. Neurochem. Res. 2000, 25:553-560.
47. Still J.L., Buell M.V., Knox E., Green D.E. Studies on the cyclophorase system; D-aspartic oxidase. J.Biol. Chem. 1949, 179:831-837.
48. Streit W.J., Braak H., Xue Q.S., Bechmann I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol. 2009, 118:475-485.
49. Van Veldhoven P.P., Brees C., Mannaerts G.P. D-aspartate oxidase, a peroxisomal enzyme in liver of rat and man. Biochim. Biophys. Acta 1991, 1073:203-208.
50. Vesce S., Rossi D., Brambilla L., Volterra A. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. Int. Rev. Neurobiol. 2007, 82:57-71.
51. Wolosker H., D'Aniello A., Snyder S.H. D-aspartate disposition in neuronal and endocrine tissues: ontogeny, biosynthesis and release. Neuroscience 2000, 100:183-189.
52. Wolosker H., Mori H. Serine racemase: an unconventional enzyme for an unconventional transmitter. Amino Acids 2012, 43:1895-1904.
53. Zhang J., Malik A., Choi H.B., Ko R.W., Dissing-Olesen L., MacVicar B.A. Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase. Neuron 2014, 82:195-207.